PROTAC HDAC6 degrader 3
Based on 1 Customer Validation
PROTAC HDAC6 degrader 3 is a selective HDAC6 PROTAC degrader with an IC50 of 0.686 μM and shows high selectivity for HDAC6 over HDAC1-4. PROTAC HDAC6 degrader 3 recruits cereblon (CRBN) to trigger HDAC6 ubiquitination and subsequent proteasomal degradation. PROTAC HDAC6 degrader 3 selectively elevates acetylated α-tubulin levels in cancer cells, and does not induce histone H3 hyperacetylation or obvious loss of cell viability. PROTAC HDAC6 degrader 3 is applicable for research on multiple myeloma.
(Pink: HDAC6 ligand (HY-171141); Blue: Cereblon ligand (HY-150803); Black: linker).
For research use only. We do not sell to patients.
- Purity: 99.81%
- Formula: C46H56F2N10O9S
- Molecular Weight:963.06
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
All PROTACs Isoforms
More
Biological Activity
|
HDAC6 0.686 μM (IC50) |
PROTAC HDAC6 degrader 3 (compound 4) selectively inhibits HDAC6 enzymatic activity with an IC50 of 0.686 μM, and is inactive against HDAC1-4 (IC50 > 30 μM)[1].
PROTAC HDAC6 degrader 3 (1 μM; 24 h) induces 74% maximal degradation of HDAC6 in MM.1S multiple myeloma cells, while sparing HDAC1 and HDAC4 and selectively increasing acetyl-α-tubulin levels[1].
PROTAC HDAC6 degrader 3 (30-90 min) potently and selectively inhibits recombinant human HDAC6, with no significant activity against recombinant human HDAC1, HDAC2, HDAC3/NcoR2, or HDAC4[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MM.1S multiple myeloma cells
-
Concentration:1 μM
-
Incubation Time:24 h
-
Result:Induced maximal HDAC6 degradation (Dmax) of 74% in MM.1S cells.
Caused no impact on HDAC1 or HDAC4 protein levels.
Selectively upregulated acetyl-α-tubulin without inducing hyperacetylation of histone H3.
Chemical Information
-
Appearance Solid
-
Molecular Weight 963.06
-
Formula C46H56F2N10O9S
-
Color White to off-white
-
SMILES
CC1=C(C2=CC=C([C@H](C)NC([C@@H]3C[C@@H](O)CN3C([C@@H](NC(COCCOCCOCC(NCC4=CC=CC(CNC5=NC=C(C6=NN=C(C(F)F)O6)C=N5)=C4)=O)=O)C(C)(C)C)=O)=O)C=C2)SC=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 100 mg/mL (103.84 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (2.60 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (2.60 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.0384 mL | 5.1918 mL | 10.3836 mL | 25.9589 mL |
| 5 mM | 0.2077 mL | 1.0384 mL | 2.0767 mL | 5.1918 mL | |
| 10 mM | 0.1038 mL | 0.5192 mL | 1.0384 mL | 2.5959 mL | |
| 15 mM | 0.0692 mL | 0.3461 mL | 0.6922 mL | 1.7306 mL | |
| 20 mM | 0.0519 mL | 0.2596 mL | 0.5192 mL | 1.2979 mL | |
| 25 mM | 0.0415 mL | 0.2077 mL | 0.4153 mL | 1.0384 mL | |
| 30 mM | 0.0346 mL | 0.1731 mL | 0.3461 mL | 0.8653 mL | |
| 40 mM | 0.0260 mL | 0.1298 mL | 0.2596 mL | 0.6490 mL | |
| 50 mM | 0.0208 mL | 0.1038 mL | 0.2077 mL | 0.5192 mL | |
| 60 mM | 0.0173 mL | 0.0865 mL | 0.1731 mL | 0.4326 mL | |
| 80 mM | 0.0130 mL | 0.0649 mL | 0.1298 mL | 0.3245 mL | |
| 100 mM | 0.0104 mL | 0.0519 mL | 0.1038 mL | 0.2596 mL |
PROTAC HDAC6 degrader 3 Related Classifications
HY-171140 Related Classifications
Powered by Bioz